Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Algernon, $50,000,000 public offering/private placement
View:
Post by talisman47 on Feb 09, 2021 6:25pm

Algernon, $50,000,000 public offering/private placement

Below information courtesy of "money shot" on Investor Hub


Here Comes The Public Offering/Private Placement:

ALGERNON PHARMACEUTICALS INC.

$50,000,000


PRELIMINARY SHORT FORM BASE SHELF PROSPECTUS

Common Shares
Warrants
Subscription Receipts
Units


Excerpt
Quote:
This preliminary short form base shelf prospectus (this “Prospectus”) relates to the offering for sale of class A common shares (the “Common Shares”), warrants (the “Warrants”) and subscription receipts (the “Subscription Receipts”) or any combination of such securities (the “Units”) (all of the foregoing, collectively, the “Securities”) by Algernon Pharmaceuticals Inc. (“Algernon” or the “Company”) from time to time, during the 25-month period that the Prospectus, including any amendments hereto, remains effective, in one or more series or issuances, with a total offering price of the Securities in the aggregate, of up to $50,000,000. The Securities may be offered for sale separately or in combination with one or more other Securities and may be sold from time to time in one or more transactions at a fixed price or prices (which may be changed) or at market prices prevailing at the time of sale, at prices determined by reference to such prevailing market prices or at negotiated prices.

https://webfiles.thecse.com/sedar_filings/00037722/2102081518070929.pdf

https://webfiles.thecse.com/sedar_filings/00037722/2102081516506706.pdf

https://webfiles.thecse.com/sedar_filings/00037722/2102081518288264.pdf

https://thecse.com/en/listings/life-sciences/algernon-pharmaceuticals-inc
Comment by CaboWabo5150 on Feb 09, 2021 6:34pm
I am a shareholder, however I am not well read in the posted materials... Can anyone elaborate, and is this favourable news or otherwise?
Comment by Mole101 on Feb 09, 2021 6:49pm
Basically they now have the option of raising funds available to them as they may see necessary for 50 million with in the next 25 months ( so when they do you don't have time to react , standard practices ......this was out on the 5th This preliminary short form base shelf prospectus (this “Prospectus”) relates to the offering for sale of class A common shares (the “Common Shares ...more  
Comment by AGNPFer on Feb 09, 2021 6:53pm
This post has been removed in accordance with Community Policy
Comment by TheBearInTheWoods on Feb 09, 2021 6:52pm
Lmao, the ole 50 million PP on the books and not in a NR! Don't worry that only 50% more dilution hahahahaha 
Comment by Mole101 on Feb 09, 2021 6:58pm
little Bear you need to learn to read before you bite ..you know it but it won't help you for the next 3 weeks as the SP is only heading up. But at some point  there will be a PP and most likely will be after results from 2b to get as much as they can .. quote=TheBearInTheWoods]Lmao, the ole 50 million PP on the books and not in a NR! Don't worry that only 50% more dilution ...more  
Comment by TheBearInTheWoods on Feb 09, 2021 7:43pm
The stock will go up high enough for a fund to short it and do another below market PP with a warrant. Just trade it properly mole boi 
Comment by Mole101 on Feb 09, 2021 8:09pm
well aware Bear .. 3 million traded on the US today, there is a wider interest about Canadian Securities south of the border and will push sp up. Thanks for the advise ; ).. quote=TheBearInTheWoods]The stock will go up high enough for a fund to short it and do another below market PP with a warrant. Just trade it properly mole boi  [/quote]  
Comment by TheBearInTheWoods on Mar 03, 2021 10:23am
Don't worry shareholders only 47,500,000 more dilution to come with the new pivot to DMT  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities